DashboardAll companies
Run this on your own research
Basic Materials · Chemicals

Nissan Chemical Corporation

4021JPX¥7,803−¥260 (−3.22%)Market closed

Price Chart

Daily

Key facts

Market Cap
¥1.05T
P/E
21.2x
P/B
4.19x
ROE
20.6%

Nissan Chemical Corporation

Basic Materials · Chemicals · FY 2026

Nissan Chemical Corporation is a prominent player in the chemical industry, specializing in the creation and development of chemicals utilized across various sectors. The company's core segments include chemicals, performance materials, agricultural chemicals, and pharmaceuticals, making it integral to industries like agriculture, electronics, and healthcare. Nissan Chemical's product offerings are diverse, ranging from basic chemicals like ammonia and melamine to advanced materials used in semiconductors and liquid crystal displays. Additionally, the company's focus on agricultural chemicals allows it to support and enhance crop yields and protection. The corporation is also involved in the pharmaceutical industry, contributing to the development and production of drugs and health-related products. Established in Japan, Nissan Chemical has a significant market presence, leveraging its technological expertise and innovative solutions to address diverse industrial needs. Its commitment to sustainable practices and environmental considerations further solidifies its role as a reliable and forward-thinking entity in the global chemical market.

CEO
Mr. Kojiro Kinoshita
Employees
3,283

Company Statistics

Valuation

P/E
21.2x
P/B
4.19x
P/S
3.77x
EV/EBITDA
12.8x
P/FCF
24.2x

Margins

Gross
46.8%
EBITDA
29.7%
Operating
22.7%
Pre-Tax
23.6%
Net
18.1%

Returns

ROA
14.7%
ROE
20.6%
ROIC
19.5%

Growth (CAGR)

Rev 3Yr
7.0%
Rev 5Yr
6.0%
Op Inc 3Yr
6.7%
Net Inc 3Yr
6.8%

Financial Health

Cash & Cash Equivalents
¥35.73B
Net Debt
¥60.30B
Debt/Equity
37.6%
Interest Cov
—

Profile

Revenue
¥279.59B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Nissan Chemical Corporation (4021) Stock Forecast 2026 ¥7,803 — Price, Financials & Analyst Targets | AlphaLenz